Status:
COMPLETED
Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Fondation de France
URC-CIC Paris Descartes Necker Cochin
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact of the global approach to the pain in cystic fibrosis patients with chronic or intermittent pain. The patients will receive in addition to an usual ...
Detailed Description
The majority of cystic fibrosis patients have chronic or intermittent pains. These pains have important consequences on the quality of life. Currently, the treatment is essentially pharmacological (es...
Eligibility Criteria
Inclusion
- Cystic fibrosis patients defined by a test sweat and / or 2 pathogenic mutations
- Patients over 10 years
- Patients with pain symptoms (VAS\> 4) recurrent (\> 4 episodes / month) or permanent since more than 6 months
- Agreement of patients, and parents (for children) for sophrology sessions conducted at home.
- Patient affiliated to social security
Exclusion
- Transplant patients or placed on a waiting list transplantation
- Patients had a patient-support by techniques hypnosis or relaxation therapy, during or within 3 months.
- Patients enrolled in another research interventional protocol.
- Women without contraception or pregnant.
Key Trial Info
Start Date :
February 15 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2014
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01915875
Start Date
February 15 2012
End Date
November 19 2014
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
hôpital Necker Enfants malades
Paris, France, 75015